AUDITORY SENSORY GATING, HIPPOCAMPAL VOLUME, AND CATECHOLAMINE METABOLISM IN SCHIZOPHRENICS AND THEIR SIBLINGS

被引:103
作者
WALDO, MC
CAWTHRA, E
ADLER, LE
DUBESTER, S
STAUNTON, M
NAGAMOTO, H
BAKER, N
MADISON, A
SIMON, J
SCHERZINGER, A
DREBING, C
GERHARDT, G
FREEDMAN, R
机构
[1] DENVER VA MED CTR,DEPT PSYCHIAT,DENVER,CO 80262
[2] UNIV COLORADO,HLTH SCI CTR C26871,DENVER,CO 80262
[3] DENVER VA MED CTR,DEPT PHARMACOL,DENVER,CO
[4] DENVER VA MED CTR,DEPT RADIOL,DENVER,CO
关键词
PATHOPHYSIOLOGY; AUDITORY EVOKED POTENTIAL; HIPPOCAMPUS; DOPAMINE; HOMOVANILLIC ACID; (SCHIZOPHRENIA);
D O I
10.1016/0920-9964(94)90067-1
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Schizophrenia may result from the concerted action of several pathophysiological factors. This pilot study compared the distribution of measurements of three such putative factors in 11 schizophrenics and their siblings: a neurophysiological deficit in auditory sensory gating, diminished hippocampal volume, and increased catecholamine metabolism. Abnormal auditory sensory gating was found in all schizophrenics in the 11 families studied and in 8 of their 20 siblings. Compared with the schizophrenics, the clinically unaffected siblings with abnormal auditory gating had larger hippocampal volume. There was no similar difference for the siblings with normal gating. The siblings with abnormal auditory gating also had lower homovanillic acid levels than the other siblings. The data suggest that a familial neuronal deficit, identified by diminished sensory gating, may be a necessary, but not sufficient factor in the pathogenesis of schizophrenia. Individuals with this deficit are generally clinically unaffected, except for schizophrenics, who also have other abnormalities, such as diminished hippocampal volume and increased catecholamine metabolism.
引用
收藏
页码:93 / 106
页数:14
相关论文
共 60 条
[1]  
ADLER LE, 1982, BIOL PSYCHIAT, V17, P639
[2]   MODULATION OF THE GATING OF AUDITORY EVOKED-POTENTIALS BY NOREPINEPHRINE - PHARMACOLOGICAL EVIDENCE OBTAINED USING A SELECTIVE NEUROTOXIN [J].
ADLER, LE ;
PANG, K ;
GERHARDT, G ;
ROSE, GM .
BIOLOGICAL PSYCHIATRY, 1988, 24 (02) :179-190
[3]   SENSORY PHYSIOLOGY AND CATECHOLAMINES IN SCHIZOPHRENIA AND MANIA [J].
ADLER, LE ;
GERHARDT, GA ;
FRANKS, R ;
BAKER, N ;
NAGAMOTO, H ;
DREBING, C ;
FREEDMAN, R .
PSYCHIATRY RESEARCH, 1990, 31 (03) :297-309
[4]  
ALTSHULER LL, 1990, ARCH GEN PSYCHIAT, V47, P1029
[5]   HOMOVANILLIC-ACID MEASUREMENT IN CLINICAL RESEARCH - A REVIEW OF METHODOLOGY [J].
AMIN, F ;
DAVIDSON, M ;
DAVIS, KL .
SCHIZOPHRENIA BULLETIN, 1992, 18 (01) :123-148
[6]  
ANDREASEN NC, 1990, ARCH GEN PSYCHIAT, V47, P1008
[7]   REPRODUCIBILITY OF THE MEASUREMENT OF PLASMA NORADRENERGIC AND DOPAMINERGIC METABOLITES IN NORMAL SUBJECTS [J].
BAKER, NJ ;
ADLER, LE ;
WALDO, M ;
GERHARDT, G ;
DREBING, C ;
COX, B ;
BERRY, S ;
PHILLIPS, W ;
FREEDMAN, R .
PSYCHIATRY RESEARCH, 1988, 23 (02) :119-130
[8]   AUDITORY SENSORY GATING IN HIPPOCAMPAL-NEURONS - A MODEL SYSTEM IN THE RAT [J].
BICKFORDWIMER, PC ;
NAGAMOTO, H ;
JOHNSON, R ;
ADLER, LE ;
EGAN, M ;
ROSE, GM ;
FREEDMAN, R .
BIOLOGICAL PSYCHIATRY, 1990, 27 (02) :183-192
[9]  
BLACKWOOD DHR, 1991, ARCH GEN PSYCHIAT, V48, P899
[10]   POSTMORTEM VOLUME MEASUREMENTS OF LIMBIC SYSTEM AND BASAL GANGLIA STRUCTURES IN CHRONIC-SCHIZOPHRENICS - INITIAL RESULTS FROM A NEW BRAIN COLLECTION [J].
BOGERTS, B ;
FALKAI, P ;
HAUPTS, M ;
GREVE, B ;
ERNST, S ;
TAPERNONFRANZ, U ;
HEINZMANN, U .
SCHIZOPHRENIA RESEARCH, 1990, 3 (5-6) :295-301